Penn Heart and Vascular

Carotid Treatments at the Vascular Surgery and Endovascular Therapy Program

Quality & Outcomes: Carotid Treatments for High–Risk Stroke Patients

Penn is a national leader in the treatment of carotid artery stenosis and stroke prevention and has performed more carotid interventions than any other medical center in the region.

Penn vascular surgeons currently treat more than 100 patients each year, with perioperative stroke and mortality rates below 1 percent.

For patients at high risk for a stroke from carotid plaque, treatments include traditional carotid endarterectomy as well as carotid stenting with distal protection. Patients with severe carotid stenosis are candidates for carotid endarterectomy while patients considered too high risk for surgery have the option of percutaneous angioplasty and stenting.

Stenosis as a result of atherosclerosis of the carotid system accounts for 25 percent of cerebrovascular accidents in the U.S. Penn is a national leader in the treatment of carotid stenosis and the development of new therapies for the condition.

Carotid Artery Stenting and Carotid Endarterectomy Procedures — 2012 Volumes

Procedure Volume Stroke and death rate
Carotid endarterectomies 81 1.35%
Carotid stents 36 <1%

A Longstanding History in Carotid Artery Treatments

Penn endovascular surgeons at took part in the first clinical trials of angioplasty and stenting for patients with severe carotid artery stenosis at high risk for carotid endarterectomy, leading to FDA approval of the first carotid stent with distal protection platform in the country.

A long-standing collaboration with Penn stroke neurologists has optimized care of patients with symptomatic and asymtomatic carotid disease.

The contributions of Penn Vascular were integral to Penn Medicine's designation as a comprehensive stroke care center.

Penn Heart & Vascular Clinical Activity Reports

See Interactive Report or Download PDF Version

Upcoming Events